ScoreWhy is Jinyu Bio-Technology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 6.64%
- The company has been able to generate a Return on Capital Employed (avg) of 6.64% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -1.07% and Operating profit at -166.78% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 303.08 MM
- CASH AND EQV(HY) Lowest at CNY 2,484.98 MM
4
With ROE of 0.68%, it has a expensive valuation with a 1.93 Price to Book Value
- Over the past year, while the stock has generated a return of 113.02%, its profits have fallen by -87.5%
- At the current price, the company has a high dividend yield of 0.3
5
Market Beating Performance
- The stock has generated a return of 113.02% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Jinyu Bio-Technology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jinyu Bio-Technology Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jinyu Bio-Technology Co., Ltd.
41.45%
1.93
44.92%
China Shanghai Composite
1.14%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.20%
EBIT Growth (5y)
-58.57%
EBIT to Interest (avg)
54.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.25
Tax Ratio
7.64%
Dividend Payout Ratio
40.39%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.08%
ROE (avg)
5.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
123
Industry P/E
Price to Book Value
2.33
EV to EBIT
1976.84
EV to EBITDA
57.71
EV to Capital Employed
2.74
EV to Sales
8.21
PEG Ratio
2.88
Dividend Yield
0.33%
ROCE (Latest)
0.14%
ROE (Latest)
1.89%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
PRE-TAX PROFIT(Q)
At CNY 41.69 MM has Grown at 296.9%
NET PROFIT(Q)
At CNY 29.43 MM has Grown at 283.57%
INVENTORY TURNOVER RATIO(HY)
Highest at 2.9 times
NET SALES(Q)
At CNY 409.98 MM has Grown at 52.98%
RAW MATERIAL COST(Y)
Fallen by -30.18% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -27.87 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Jinyu Bio-Technology Co., Ltd.
Pre-Tax Profit
At CNY 41.69 MM has Grown at 296.9%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 29.43 MM has Grown at 283.57%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 409.98 MM has Grown at 52.98%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Inventory Turnover Ratio
Highest at 2.9 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debt-Equity Ratio
Lowest at -27.87 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -30.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jinyu Bio-Technology Co., Ltd.
Non Operating Income
Highest at CNY 0.39 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
